Chronic toxicity, genotoxic assay, and phytochemical analysis of four traditional medicinal plants

Journal of Medicinal Food

Volumn 14, Issue 9, 2011, Pages 1018-1022

  Sortibrán, América Castañeda ^a   Téllez, María Guadalupe Ordaz ^a   Ocotero, Verónica Muñoz ^a   Carballo Ontiveros, Marco Antonio ^a   García, Angélica Méndez ^a   Valdés, Rocio Jimena Jiménez ^a   Gutiérrez, Elizabeth Romero ^a   Rodríguez Arnaiz, Rosario ^a  

^a UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

Author keywords

chronic toxicity; genotoxicity; Ligusticum porteri; Monarda austromontana; phytochemical analysis; Poliomintha longiflora; Tecoma stans

Indexed keywords

ALKALOID DERIVATIVE; FLAVONOID; LIGUSTICUM PORTERI EXTRACT; MITOMYCIN C; MONARDA AUSTROMONTANA EXTRACT; PHENOL DERIVATIVE; PHYTOSTEROL; PLANT EXTRACT; POLIOMINTHA LONGIFLORA EXTRACT; TANNIN DERIVATIVE; TECOMA STANS EXTRACT; TRITERPENOID; UNCLASSIFIED DRUG;

ARTICLE; CHEMICAL COMPOSITION; CHRONIC DRUG ADMINISTRATION; CHRONIC TOXICITY; DROSOPHILA MELANOGASTER; DRUG ISOLATION; GENOTOXICITY; LARVA; LIGUSTICUM PORTERI; MEDICINAL PLANT; MONARDA AUSTROMONTANA; NONHUMAN; PHYTOCHEMISTRY; POLIOMINTHA LONGIFLORA; PRIORITY JOURNAL; TECOMA STANS; TRADITIONAL MEDICINE;

ANIMALS; BIGNONIACEAE; CENTRAL AMERICA; DROSOPHILA; FEMALE; LAMIACEAE; LARVA; LIGUSTICUM; MALE; MEDICINE, TRADITIONAL; MUTAGENICITY TESTS; MUTAGENS; PLANT EXTRACTS; PLANT LEAVES; PLANT ROOTS; PLANTS, MEDICINAL; SOUTH AMERICA; TOXICITY TESTS, CHRONIC;

DROSOPHILA MELANOGASTER; LIGUSTICUM PORTERI; MONARDA AUSTROMONTANA; POLIOMINTHA; TECOMA STANS;

EID: 80052013404     PISSN: 1096620X     EISSN: 15577600     Source Type: Journal    
DOI: 10.1089/jmf.2010.0178     Document Type: Article

References (23)

1. Bye R, Linares E, Estrada E: Biological diversity of medicinal plants in Mexico. In: Phitochemistry of Medicinal Plants. Ar-nason JT (ed). New York, Plenum Press, 1995, pp. 65-82.
2. Rzedowski J: Vegetación en México. 6th ed, México, Distrito Federal, México, Editorial Limusa, 1993.
3. Argueta A, Cano ME, Rodarte ME: Atlas de las Plantas Medi-cinales de la Medicina Tradicional Mexicana. México, Distrito Federal, México, Instituto Nacional Indigenista, 1994.
4. Roman-Ramos R, Flores Saenz JL, Partida Hernandez G, Lara-Lemus A, Alarcón-Aguilar F: Experimental study of the hypo-glycemic effect of some antidiabetic plants. Arch Invest Med (Mex) 1991;22:87-93.
5. Loyoza M, Mellado-Campos V: Is the Tecoma stans infusion an antidiabetic remedy? J Ethopharmacol 1985;14:1-9. (Pubitemid 16244306)
6. Constantino L, Raimondi L, Prisino R, et al.: Isolation and pharmacological activities of the Tecoma stans alkaloids. Il Farmaco 2003;58:781-785. (Pubitemid 37122648)
7. Deciga-Campos M, González-Trujano E, Navarrete A, Mata R: Anticonceptive effect of selected Mexican traditional medicinal species. Proc West Pharmacol Soc 2005;48:70-72. (Pubitemid 43053805)
8. Daniels AL, Van Slambrouck S, Lee RK, et al.: Effects of extracts from two Native American plants on proliferation of human breast and colon cancer cell lines in vitro. Oncol Rep 2006;15:327-331.
9. Inoue S, Takahashi M, Abe S: Inhibitory activity of hydrosols, herbal teas and related essential oils against filament formation and the growth of Candida albicans. Nippon Ishinkin Gakkai Zassh 2009;50:243-251.
10. Gwinn KD, Ownley BH, Greene SE, et al.: Role of essential oils in control of rhizoctonia damping-off in tomato with bioactive Monarda herbage. Phytopathology 2010;100:493-501.
11. Castillo JI, Gonzales V, Jaime-Aguilar H, et al.: Anti-Helicobacter pylori activity of plants used in Mexican traditional medicine for gastrointestinal disorders. J Ethnopharmacol 2009;122: 402-405.
12. Zheng W, Wang Y: Antioxidant activity and phenolic compounds in selected herbs. J Agricult Food Chem 2001;49:5165-5170. (Pubitemid 33089648)
13. Deciga-Campos M, Rivero-Cruz I, Arriaga-Alba M, et al.: Acute toxicity and mutagenic activity of Mexican plants used in traditional medicine. J Ethnopharmacol 2007;110:334-342.
14. Harborne JB: Phytochemical Methods: A Guide to Modern Techniques of Plant Analysis. London, Chapman and Hall, 1984, pp. 4-32.
15. Trease GE, Evans WC: Pharmacognosy. 15th ed. London, Saunders, 2002.
16. Lindsley DL, Zimm GG: The Genome of Drosophila melanoga-ster. San Diego, Academic Press, 1992.
17. Graf U, Würgler F, Katz A, et al.: Somatic mutation and recombination test in Drosophila melanogaster. Environ Mutagen 1984;6:153-188. (Pubitemid 14118501)
18. Frei H, Würgler F: Statistical methods to decide whether mutagenicity test data from Drosophila assays indicate a positive, negative or inconclusive result. Mutat Res 1988;203: 297-308.
19. Frei H, Würgler FE: Optimal experimental design and sample size for the statistical evaluation of data from somatic mutation and recombination test (SMART) in Drosophila. Mutat Res 1995;334:247-258.
20. Graf U, Frei H, Kägi, Katz AJ, Würgler FE: Thirty compounds tested in the Drosophila wing spot test. Mutat Res 1989;222:359-373. (Pubitemid 19096710)
21. Vogel EW, Graf U, Frei HJ, Nivard MM: The results of assays in Drosophila as indicators of exposure to carcinogens. IARC Sci Publ 1999;146:427-470.
22. Abraham SK, Singh SP, Kesavan PC: In vivo antigenotoxic effects of dietary agents and beverages co-administrated with urethane: assessment of the role of glutathione S-transferase activity. Mutat Res 1998;413:103-110. (Pubitemid 28277069)
23. Bridges CB, Morgan TH: Carnegie Inst Washington Publ 1923; 327:59,99,184.